2016 № 1 The paradoxes of health care funding in 2016: the system of mandatory health care insurance policies recorded extra funds, which will be withdrawn back into the federal budget
With all complexity of current economic landscape in the country, health care remains to be one of the top priority spheres regarding financing. Despite the crisis, the volume of funds, allocated to the field is gradually increasing. However, the growth rates of spending on health care lag behind the rates of inflation. Furthermore, a significant part of the budget of Federal Fund of the mandatory medical insurance policy is not connected with the provision of medical aid in the medical mandatory insurance system. Expenditure of Mandatory Medical Insurance System is not oriented on President’s orders to increase the salaries. And despite the presence of crucial financial issues in the mandatory medical insurance system, substantial funds are withdrawn from the Federal budget of Mandatory Medical Insurance system into the federal budget.
2018 № 1 Prospects of health financing in 2018
New 2018 in terms of funding health care will differ from the previous - it is expected a sharp increase in funding from all types of sources. However, this is due not only to increased revenues and the restructuring expenses. It becomes more rational - "saving" (for example, reducing expenditures on more costly inpatient care in the Federal budget). In the system of obligatory medical insurance is the refusal of a number of "non-core" expenditure. All of this should have a positive impact on the development of health care
2013 № 7 Analysis of international experience of funding and managing research and development in healthcare (Federal Research Institute for Health Care Organization and Information of the Ministry of Health of Russian Federation, Moscow, Russia; Research center of neurology Russian academy of medical science, Moscow, Russia; Research-Practical Center of Medical Radiology, Moscow Department of Health care, Moscow, Russia)
Healthcare in developed countries becomes the most productive and cited field of the world science. However little is known about innovative processes in the non-market oriented areas including medicine. This article deals with funding and managing research and development in medicine in foreign countries. The authors show that innovations in healthcare are the major focus of interest of foreign governments seeking for balance between cost-containment, quality and access to health care. Healthcare innovations assessment is necessarily accompanied with the expert evaluation of efficacy and safety of health technologies delivered by designated institutions. International policy analysis confirms that the search for the most effective management in organization and funding of healthcare research is of high priority in the world.